Since Moraxella catarrhalis is a common cause of otitis media in children and respiratory tract infections in adults with chronic obstructive pulmonary disease (COPD), there is considerable interest in developing vaccines to prevent these infections. In order to have a rational approach to developing a vaccine to prevent infections due to M. catarrhalis, it is important to know what constitutes a protective immune response. The approach to elucidating a protective immune response to infection caused by M. catarrhalis will involve studies with epidemiologically well defined clinical samples from a prospective study of COPD. The prospective study design and the well characterized samples provide the opportunity to identify immune responses which mediate protection from infection and/or clearance of M. catarrhalis from the human respiratory tract. The systemic and mucosal immune response will be studied in samples from patients who have cleared M. catarrhalis from their respiratory tracts and from adults who have experienced recurrent infections due to M. catarrhalis. Correlating the results of immunoassays with the subsequent clinical and microbiological outcome will allow predictions regarding immune responses which mediated clearance of colonization. Samples will be subjected to a series of several immunoassays to elucidate the nature of protective immune responses in humans. Such information is critical in developing a rational strategy for testing potential vaccine antigens for M. catarrhalis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI046422-01A1
Application #
6345797
Study Section
Microbiology and Infectious Diseases Research Committee (MID)
Project Start
2001-03-01
Project End
2006-02-28
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
State University of New York at Buffalo
Department
Type
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Luke-Marshall, Nicole R; Edwards, Katie J; Sauberan, Shauna et al. (2013) Characterization of a trifunctional glucosyltransferase essential for Moraxella catarrhalis lipooligosaccharide assembly. Glycobiology 23:1013-21
Schwingel, Johanna M; Edwards, Katie J; Cox, Andrew D et al. (2009) Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies. Infect Immun 77:4548-58
Schwingel, Johanna M; St Michael, Frank; Cox, Andrew D et al. (2008) A unique glycosyltransferase involved in the initial assembly of Moraxella catarrhalis lipooligosaccharides. Glycobiology 18:447-55
Adlowitz, Diana G; Kirkham, Charmaine; Sethi, Sanjay et al. (2006) Human serum and mucosal antibody responses to outer membrane protein G1b of Moraxella catarrhalis in chronic obstructive pulmonary disease. FEMS Immunol Med Microbiol 46:139-46
McMahon, Michelle; Murphy, Timothy F; Kyd, Jennelle et al. (2005) Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity. Vaccine 23:3590-6
Murphy, Timothy F; Brauer, Aimee L; Aebi, Christoph et al. (2005) Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease. Infect Immun 73:8161-6
Edwards, Katie J; Allen, Simon; Gibson, Bradford W et al. (2005) Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly. J Bacteriol 187:2939-47
Murphy, Timothy F; Brauer, Aimee L; Aebi, Christoph et al. (2005) Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease. Infect Immun 73:3471-8
Murphy, Timothy F; Brauer, Aimee L; Grant, Brydon J B et al. (2005) Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med 172:195-9
Edwards, Katie J; Schwingel, Johanna M; Datta, Anup K et al. (2005) Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates. J Clin Microbiol 43:6139-43

Showing the most recent 10 out of 19 publications